TSX closed
Loading markets…

Advertisement

Stocks

Why Bausch Health Companies Inc stock fell yesterday

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:BHC.TO

Follow BHC

Photos provided by Pexels

Bausch Health Companies Inc experienced a notable decline in its stock price, closing down 4.06% in yesterday's trading session.

Bausch Health Companies Inc (BHC.TO) faced a tough trading day, with its stock falling 4.06% to close at CA$8.50. This drop reflects ongoing concerns among investors about the company's market expansion and product access initiatives.

Advertisement

Bausch Health Companies Inc

BHC.TO

Full stock page →

BHC.TO

Bausch Health Companies Inc

Source:WealthAwesomeWealthAwesome
$0.41 (5.28%)
120 day period
$6.25$7.95$9.65Apr 1Jun 26Sep 22

Market cap

$3.06B

52W high

$11.08

52W low

$6.10

1W change

+3.68%

Beta

0.37

Analyst Price Targets

Based on analyst covering BHC · as of Sep 17, 2026

📉

Wall Street analysts forecast BHC stock price to fall 14.2% over the next 12 months.

Consensus

Moderately Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$7.01

-14.2% Upside

Current Price

C$8.17

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BHC's historical volatility

HistoricalForecast68%95%
C$5.19C$7.49C$9.78C$12.08C$14.38C$16.67TodayMay 14Jul 20Sep 22Nov 4Dec 18Jan 30

30-Day Vol

46.3%

Annualized

90-Day Vol

66.6%

Annualized

Trend (90d)

+36.5%

Annualized drift

90d Mean

C$9.31

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$8.53C$7.27C$10.01
60 trading daysC$8.91C$7.11C$11.17
90 trading daysC$9.31C$7.06C$12.27

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should stay cautious as Bausch Health navigates its growth strategy while dealing with potential market volatility and competition in the pharmaceutical sector.

Stock Price Decline of 4.06%

Bausch Health's market cap is now about CA$3.18 billion, which highlights investor worries about its financial stability and growth prospects.

Bull case

Bausch Health's recent expansion into new markets, especially in EMEA and Mexico, could boost its revenue and brand presence. This is particularly true with the launch of innovative skincare solutions that may attract more customers.

Bear case

The significant drop in stock price might show that investors are skeptical about the company's ability to keep up its momentum. This skepticism is especially relevant given its ongoing struggles with profitability and competition in the market.

Market Performance Overview

Advertisement

In yesterday's trading session, Bausch Health Companies Inc stock fell by 4.06%, closing at CA$8.50. This decline is notable considering the company's recent efforts to expand its presence in dermatology and skincare solutions. Investors may be weighing these expansion efforts against the backdrop of ongoing profitability challenges.

Recent Developments and Strategic Moves

Bausch Health recently announced a collaboration with YUN to improve access to microbiome-friendly skincare products in Mexico and several EMEA markets. While this strategic move aims to enhance the company's portfolio, the market's reaction suggests some skepticism about its effectiveness in driving immediate revenue growth.

Investor Sentiment and Future Outlook

The drop in stock price may reflect broader concerns among investors about Bausch Health's ability to sustain growth amidst competitive pressures and its current financial performance. As the company continues to navigate these challenges, investors should keep a close eye on its upcoming quarterly results and market strategies.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 10, 2026
Last Updated: September 21, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement